2022
DOI: 10.3389/fonc.2022.1061438
|View full text |Cite
|
Sign up to set email alerts
|

CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14)

Abstract: ObjectiveTranslocation (11;14) is one of the most frequent recurrent cytogenetic abnormalities in multiple myeloma (MM), while its clinical prognostic value remains controversial. CD20 expression is uncommon in MM while strongly associated with t(11;14). This study aimed to investigate whether CD20 could provide further prognostic value in MM patients harboring t(11;14).MethodsCD20 expression detected by flow cytometry was retrospectively analyzed in 211 newly diagnosed MM patients with t(11;14). The clinical … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 33 publications
0
3
0
Order By: Relevance
“…26 Although CD20 is a transmembrane phosphoprotein commonly expressed at different stages of B lymphocyte differentiation, its atypical expression in plasmacytic neoplasms is poorly described, and it has already occurred in cases of MM in humans and extramedullary plasmacytomas in dogs. 24,27 The presence of hypercalcemia, Bence-Jones proteinuria, and extensive bone lysis are considered negative prognostic factors in the dog, 5 but none of these alterations were observed in the present case reports. However, the presence of CD20 marking in neoplastic plasma cells from the cell blocks of two animals may be related to longer survival times after diagnosis and initiation of adequate treatment.…”
Section: Discussionmentioning
confidence: 45%
See 2 more Smart Citations
“…26 Although CD20 is a transmembrane phosphoprotein commonly expressed at different stages of B lymphocyte differentiation, its atypical expression in plasmacytic neoplasms is poorly described, and it has already occurred in cases of MM in humans and extramedullary plasmacytomas in dogs. 24,27 The presence of hypercalcemia, Bence-Jones proteinuria, and extensive bone lysis are considered negative prognostic factors in the dog, 5 but none of these alterations were observed in the present case reports. However, the presence of CD20 marking in neoplastic plasma cells from the cell blocks of two animals may be related to longer survival times after diagnosis and initiation of adequate treatment.…”
Section: Discussionmentioning
confidence: 45%
“…However, the presence of CD20 marking in neoplastic plasma cells from the cell blocks of two animals may be related to longer survival times after diagnosis and initiation of adequate treatment. A study of a specific cytogenetic group of humans newly diagnosed with MM proposes that unusual CD20 expression may be a favorable prognostic factor with a tendency toward longer survival, 27 which, despite the small number of cases showed in this study, suggests that the use of cell block and immunohistochemistry may also be relevant in the investigation of a possible prognostic factor in dogs with MM, which should be studied.…”
Section: Discussionmentioning
confidence: 76%
See 1 more Smart Citation